DSM Policies for Extramural Clinical Trials and Clinical Research 4
• Individual or group that will be responsible for trial monitoring and advising the
appointing entity
• How the confidentiality of participant data will be protected
• Ensuring the overall assent and consent process for all participants including
special needs populations, such as, but not limited to, children, individuals with
developmental disabilities, individuals with intellectual disabilities, and vulnerable
populations
• Management of incidental findings, such as aberrant findings on imaging scans
or other assessments conducted as part of the research protocol
• How protocol violations will be handled by the principal investigator (PI) (The
term protocol deviation is also used to refer to any other unplanned instance of
protocol noncompliance https://www.hhs.gov/ohrp/sachrp-
committee/recommendations/2012-march-30-letter-attachment-c/index.html)
DSMP Review Process
The DSMP in the competing application will be considered during peer review and by
the NICHD program officer (PO) after review. If concerns are identified, the applicant will
modify the plan in conjunction with program staff. Following approval, the applicant will
enter the approved revised plan into the Human Subjects System.
If further modifications to the DSM plan are made before the trial begins, the revised
monitoring plan must be submitted to NICHD and the IRB for approval before initiating
the trial. The grantee or awardee must promptly request approval from NICHD staff prior
to making any changes in the DSMP during the award/contract.
For all clinical trials and clinical research for which NICHD may require a DSMP,
approval of the DSMP must be obtained from the IRB before the trial/study begins.
NICHD will indicate in the Notice of Award that the recipient may not recruit participants
until: (1) the DSMP has been approved by NICHD, and (2) the NICHD-funded
investigator’s IRB has approved the DSMP.
NICHD POs may determine that a clinical trial or clinical research study needs a
different level of monitoring than determined by the applicant/offeror or awardee.
NICHD DSMB Policy
All NIH-sponsored multisite clinical trials that pose potential risk and some single site
clinical trials require DSMB oversight. A DSMB is an independent group of experts
charged with reviewing study data for integrity, participant safety, study conduct and
progress, and providing directives regarding study continuation, modification, and